To further investigate the molecular signaling pathways of MMP inhibition by cysteamine treatment, we conducted western blots for transglutaminase 2 (TGM2) and extracellular matrix proteins such as N-cadherin (an invasion promoter) and E-cadherin (a tumor suppressor). This evidence concerns the gene TGM2 and neoplasm.